LISTEN: San Diego Physician on FDA Full Approval of Pfizer Vaccine


The Food and Drug Administration Monday issued full approval to the two-dose Pfizer COVID-19 vaccine.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic," acting FDA Commissioner Janet Woodcock said in a statement. "While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product.”

The full approval for the vaccine, which will now be marketed under the name "Comirnaty," applies to people 16 and older. The vaccine is still available for kids aged 12 through 15 under emergency use authorization.

(Photo Getty Images)

placeholder image

Photo: Getty Images


Sponsored Content

Sponsored Content